Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study.

Thaçi, Diamant; Tziotzios, Christos; Ito, Taisuke; Ko, Justin; Karadag, Ayse Serap; Fang, Hong; Edwards, Roger A; Bonfanti, Gianluca; Wolk, Robert; Tran, Helen; Law, Ernest

Thaçi, Diamant; Tziotzios, Christos; Ito, Taisuke; Ko, Justin; Karadag, Ayse Serap; Fang, Hong; Edwards, Roger A; Bonfanti, Gianluca; Wolk, Robert; Tran, Helen; Law, Ernest.

Affiliation

Thaçi D; Institut and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany.
Tziotzios C; St. John's Institute of Dermatology, King's College London, London, UK.
Ito T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Ko J; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
Karadag AS; Department of Dermatology, School of Medicine, Memorial Health Group, Istanbul Arel University, Istanbul, Turkey.
Fang H; Department of Dermatology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou City, China.
Edwards RA; Health Services Consulting Corporation, Boxborough, MA, USA.
Bonfanti G; Engineering Ingegneria Informatica, SPA, Milan, Italy.
Wolk R; Pfizer Inc, Groton, CT, USA.
Tran H; Pfizer Inc, New York, NY, USA.
Law E; Pfizer Inc, New York, NY, USA. ernest.law@pfizer.com.

Dermatol Ther (Heidelb) ; 13(11): 2621-2634, 2023 Nov.

Article in En | MEDLINE | ID: mdl-37707764

Key words

Alopecia areata; Hair loss; Latent class analysis; Ritlecitinib

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Dermatol Ther (Heidelb) Year: 2023 Document type: Article Affiliation country: Alemania Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google